Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 13, Issue 3, 2000, Pages 184-187

  Allen, Daniel N ^a   Goldstein, Gerald ^b,c   Forman, Steven D ^b,c   Keshavan, Matcheri S ^c   Van Kammen, Daniel P ^d   Sanders, Richard D ^b,c,e  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Robert Wood Johnson P   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZATROPINE; HALOPERIDOL;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; HUMAN; MALE; MEDICAL RECORD; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; PERCEPTION DISORDER; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; COGNITION; DIAGNOSIS, DUAL (PSYCHIATRY); FACTOR ANALYSIS, STATISTICAL; HUMANS; INPATIENTS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PERCEPTION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0033930051     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cuffel BJ. Prevalence estimates of substance abuse in schizophrenia and their correlates. J Nerv Ment Dis 1992;180:589-92.
2. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31-56.
3. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990;264: 2511-8.
4. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatr Neurosci 1997;2:99-104.
5. Cleghorn JM, Kaplan RD, Szechttnan B, et al. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry 1991;52:26-30.
6. Nixon SJ, Hallford HG, Tivis RD. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res 1996;64:35-45.
7. Sevy S, Kay SR, Opler L, van Praag HM. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990;178:642-8.
8. Allen DN, Goldstein G, Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology 1999;13:62-8.
9. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson. AZ: Neuropsychology Press, 1993.
10. Russell EW, Neuringer C, Goldstein G. Assessment of brain damage: a neuropsychological key approach. New York: Wiley-Interscience, 1970.
11. Buchanan RW, Heinrichs DW. The neurologic evaluation scale (NES): a structured instrument for the assessment of neurologic signs in schizophrenia. Psychiatry Res 1989;27:335-50.
12. Keenan E, O'Donnell C, Sinanan K, O'Callaghan E. Severity of alcohol dependence and its relationship to neurologic soft signs, neuropsychological impairment and family history. Acta Psychiatr Scand 1997;95:272-6.
13. Duncan E, Sanfilipo N, Wieland S, et al. Neurologic soft signs in schizophrenia: relationship to thought disorder. Biol Psychiatry 1994;35:715 (abstract).
14. Schroder J, Niethammer R, Geider FJ, et al. Neurologic soft signs in schizophrenia. Schizophr Res 1992;6:25-30.
15. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, 1989.
16. Drake RE, Osher FC, Noordsy DL, et al. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67.
17. Wechsler D. Manual for the Wechsler adult intelligence scale-revised. San Antonio, TX: Psychological Corporation, 1981.
18. Sanders RD, Forman SD, Pierri JN, et al. Inter-rater reliability of the neurologic examination in schizophrenia. Schizophr Res 1998;29: 287-92.
19. Sanders RD, Forman SD, Gupta B, et al. Factor structure of the Neurologic Evaluation Scale. Biol Psychiatry 1996;39:548 (abstract).
20. Andreasen N. Modified scale for the assessment of negative symptoms (SANS). Iowa City, IA: The University of Iowa, 1984.
21. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
22. 31P magnetic resonance spectroscopy studies of developing brain. In: Keshavan MS, Murray RM, eds. Neurodevelopment and adult psychopathology. Cambridge, UK: University of Cambridge Press;1997:71-92.
23. Schlaepfer TE, Harris GJ, Tien AY, et al. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151:842-8.
24. Sullivan EV, Mathalon DH, Lim KO, et al. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol Psychiatry 1998;43:118-31.
25. Andreasen NC, Paradiso S, O'Leary DS. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 1998;24:203-18.
26. Martin P, Albers M. Cerebellum and schizophrenia: a selective review. Schizophr Bull 1995;21:241-50.
27. Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 1998;155:1288-90.
28. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurologic signs of cerebellar and cortical sensory dysfunction in schizophrenics and their relatives. Schizophr Res 1999;11:99-104.
29. Lane A, Colgan K, Moynihan F, et al. Schizophrenia and neurologic soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res 1996;64:105-114.
30. Malla AK, Norman RM, Aguilar O, Cortese L. Relationship between neurologic "soft signs" and syndromes of schizophrenia. Acta Psychiatr Scand 1997;96:274-80.